Koye Pharmaceuticals Pvt ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimipack MV 2 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimipack MV 2 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimipack MV 2 Tablet SR is to be taken empty stomach.
Glimipack MV 2 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimipack MV 2 Tablet SR is a combination of the active ingredients Glimepiride, Metformin and Voglibose. This medicine is used to treat type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with a healthy diet and regular exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and enhances insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels in the body. This combination is not recommended for Type 1 DM treatment.
Common side effects associated with Glimipack MV 2 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infections. If any serious or unusual side effects occur, seek medical attention immediately.
Glimipack MV 2 Tablet SR should not be used if the patient has an allergy to any of the components or excipients. It is also unsuitable for patients with moderate to severe kidney disease and inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis including diabetic ketoacidosis.
No, taking Glimipack MV 2 Tablet SR with alcohol is not advisable. This can lower your blood sugar (hypoglycemia) levels and increase the risk of lactic acidosis.
Yes, Glimipack MV 2 Tablet SR can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. Hypoglycemia is more likely to occur if you miss meals, consume alcohol, over-exercise, or take other antidiabetic medications together. Regular blood sugar monitoring is crucial.
Keep this medicine in its original packaging, tightly closed, and store it as instructed on the label. Do not misuse or waste the medication; ensure it is out of reach of children, pets, and other individuals.